Xiaoqun Ye
Overview
Explore the profile of Xiaoqun Ye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
206
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang Y, Dong C, Ma X, Wang Y, Li Z, Xu Y, et al.
J Mater Chem B
. 2025 Feb;
13(9):2978-2999.
PMID: 39901728
Cuproptosis, a newly identified programmed cell death form, is characterized by excessive copper accumulation in cells, resulting in mitochondria damage and toxic protein stress, ultimately causing cell death. Given the...
2.
Cai S, Yang W, Luo H, Li Z, Huang X, Li J, et al.
PLoS One
. 2024 Nov;
19(11):e0313221.
PMID: 39514581
Background: Nowadays, the characteristics and treatment of combined small-cell lung carcinoma (CSCLC) remain controversial. This study aimed to analyze the features of clinical demographics, survival outcomes and treatment modalities among...
3.
Chen Y, Zhu S, Yang L, Lu Y, Ye X
Curr Mol Med
. 2024 Oct;
PMID: 39473098
Background And Aim: Cancer-associated fibroblasts (CAFs), one of the most abundant stromal cell types in tumor microenvironment (TME), have been a potential target for cancer treatment such as lung cancer....
4.
Li Z, Ma X, Yang Y, Wang Y, Zhu W, Deng X, et al.
Acta Biomater
. 2024 Jul;
185:381-395.
PMID: 39067643
Crizotinib (CRZ), one of anaplastic lymphoma kinase tyrosine kinase inhibitors (ALK-TKIs), has emerged as a frontline treatment for ALK-positive (ALK+) lung adenocarcinoma. However, the overexpression of P-glycoprotein (P-gp, a mitochondrial...
5.
Li Z, Wu Y, Yang W, Wang W, Li J, Huang X, et al.
Front Cell Dev Biol
. 2024 Apr;
12:1331759.
PMID: 38650895
Background: Polyamine modification patterns in lung adenocarcinoma (LUAD) and their impact on prognosis, immune infiltration, and anti-tumor efficacy have not been systematically explored. Methods: Patients from The Cancer Genome Atlas...
6.
Yang W, Wu Z, Cai S, Li Z, Wang W, Wu J, et al.
Front Immunol
. 2024 Apr;
15:1354339.
PMID: 38638428
Background: Lymphangiogenesis (LYM) has an important role in tumor progression and is strongly associated with tumor metastasis. However, the clinical application of LYM has not progressed as expected. The potential...
7.
Li H, Wang J, Li X, Zhu X, Guo S, Wang H, et al.
Spectrochim Acta A Mol Biomol Spectrosc
. 2023 Nov;
306:123596.
PMID: 37925957
Lungcancer remains the leading cause of cancer related deaths in worldwide. Earlydiagnosis oflungcancer can significantly improve survival rate. However, due to its close resemblance to the malignant nodules, the possible...
8.
Su K, Liu H, Ye X, Jin H, Xie Z, Yang C, et al.
Mol Genet Genomic Med
. 2023 Oct;
12(1):e2280.
PMID: 37789575
Backgrounds: Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, a severe congenital malformation of the female genital tract, is a highly heterogeneous disease which has no clear etiology. Previous studies have suggested that copy number...
9.
Yang W, Wang W, Li Z, Wu J, Huang X, Li J, et al.
Crit Rev Oncol Hematol
. 2023 Sep;
191:104136.
PMID: 37716517
Small cell lung cancer (SCLC) is one of a pathological type of lung cancer, and it is characterized by invasiveness, high malignancy and refractoriness. The mortality rate of SCLC is...
10.
Yang W, Li Z, Wang W, Wu J, Li J, Huang X, et al.
Front Genet
. 2023 Jun;
14:1206141.
PMID: 37351348
Lung cancer has a high incidence and mortality rate worldwide. Vasculogenic mimicry (VM) is a specific modality of tumor angiogenesis that could potentially be a new target for tumor therapy....